Almirall, S A : Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
BARCELONA, February 19, 2024 Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its full-year 2023 financial results.
Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases The Phase I study will evaluate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of ALM27134 ALM27134 has the potential to treat underserved patien.
LUND, Sweden, July 21, 2022 /PRNewswire/ Cantargia (Cantargia AB) (Nasdaq: CANTA) (Stockholm: CANTA) today announced that the United States Patent and Trademark Office (USPTO) has issued
/PRNewswire/ Cantargia (Cantargia AB) (Nasdaq: CANTA) (Stockholm: CANTA) today announced that the United States Patent and Trademark Office (USPTO) has.